glp 1 agonist vision loss GLP-1 Receptor Agonists and risk Recent reports have raised concerns
Description
As prescriptions increased, patients and clinicians began reporting a wider range of adverse effects beyond those described in early clinical trials
doi:10.2337/db18-0317 12
Does the VA cover GLP-1 medications
J Diabetes Investig 7 Suppl 1: 7679
Diabetes promotes the progression of MASLD to steatohepatitis, cirrhosis, and hepatocellular carcinoma
